4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001209191-22-044412
Chief Development Officer sold 988 shares at $16.81 ($16,608)
From the SEC's structured data for this filing
Trades in this filing
Curley Joanne · Chief Development Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-08-03 | Sale : show line 1 in the form | −988 | $16.81 | $16,608 | 17,285 | D |
| Open-market sales · 988 sh · avg $16.81 · $16,608 | ||||||
Loading xslF345X03/doc4.xml…